Eshwari Kovoor

Dr. Eshwari Kovoor has more than 14 years of experience leading and executing Phase 1-4 clinical trials in diverse therapeutic areas including rare and orphan disease, endocrinology, pediatric, cardiovascular disease, oncology, pulmonary and critical care, gynaecology and, musculoskeletal diseases. During this time, Dr. Kovoor has held drug development roles of increasing seniority at Stanford Hospital, Fogarty Innovation, Abbvie and including as Lead Medical Monitor at Ascendis Pharma. While at Ascendis Pharma, Dr. Kovoor led the TransCon PTH Phase 1 First-In-Human study into phase 2 clinical development. Dr. Kovoor completed her medical training at the NTR University of Health Sciences (India) and her training in clinical research at Michigan State University (USA).